What does it mean to compare two stocks like Oscar Health and Upstart on a single page?

A stock comparison aligns each company’s business model, financial metrics, and market context side by side. It highlights how Oscar Health and Upstart generate revenue, manage costs, and face industry risks. The aim is to help readers understand differences in strategy, financial health, and growth potential without implying any investment action.

How should I read the pros and cons for each stock?

Pros and cons summarise expected strengths and potential risks from the provided context. For example, Oscar Health’s growth and efficiency are positives, while its losses and volatility are downsides. Upstart’s AI platform is a strength, whereas regulatory or macro risks may temper its outlook. These points aid comparison and context-building.

What market factors influence both Oscar Health and Upstart?

Both stocks operate in sectors affected by macroeconomic conditions, including interest rates and healthcare or lending demand. Regulatory scrutiny can shape performance, while technology-driven business models may magnify volatility. The broader market environment often drives investor sentiment and valuation moves for both names.

How does revenue growth relate to profitability in this comparison?

Revenue growth reflects top-line expansion, a feature for both stocks. However, profitability concerns arise when costs outpace revenue, as seen with Oscar Health's ongoing losses. Upstart’s growth may align with margins if unit economics scale, but profitability is not guaranteed amid market or regulatory challenges.

What role does risk play when evaluating these two stocks?

Risk encompasses volatility, regulatory exposure, and sensitivity to macro conditions. Oscar Health shows a higher beta, indicating greater price swings, while Upstart faces regulatory and demand-cycle risks. Understanding these risks helps calibrate how each stock might respond to market news or policy shifts.

Why might analysts’ price targets differ from current prices for these stocks?

Analysts weigh growth prospects, margins, and risk factors differently, leading to varied price targets. For Oscar Health, some targets could imply downside even amid growth expectations due to losses. For Upstart, targets reflect views on platform scalability and regulatory risk. Market price often reflects new information quickly.

Which metrics should a beginner focus on when reading this page?

Begin with revenue growth, profitability signals (earnings, margins), and cost efficiency (SG&A ratio). Then consider volatility (beta) and any regulatory or legal concerns. This combination helps readers assess growth potential against risk, without relying solely on price movements.

How do business models affect long-term outlook in this comparison?

Oscar Health relies on technology and data to manage costs and member experience, influencing cash burn and expansion pace. Upstart leverages an AI-driven lending platform with scalable margins but faces macro and regulatory headwinds. Business model differences shape resilience to cycles and capital needs.

What does the context say about how to interpret the numbers?

The context presents qualitative and quantitative signals: growth rates, efficiency measures, profitability status, and risk flags. Use them as lenses rather than verdicts. Numbers tell a part of the story; policy, competition, and consumer demand also influence outcomes over time.

How should I treat high volatility when comparing these stocks?

Higher volatility suggests greater potential price swings. For Oscar Health, a beta above 1.8 indicates amplified moves. Upstart may also experience swings due to growth expectations and regulatory considerations. Consider the volatility alongside your risk tolerance and investment horizon.

What educational takeaway does this page aim to provide?

The page offers neutral, accessible information to help readers understand how Oscar Health and Upstart operate and compete. It explains core concepts, key metrics, and market context without advising on buy or sell decisions, emphasising educational purposes and informed comparison.

Oscar Health vs Upstart

Oscar Health sells individual and small-group health insurance plans powered by its own technology platform while Upstart uses AI to underwrite personal and auto loans at a pace that traditional lenders can't match, pairing two data-driven financial platforms that took very different paths through the rising-rate environment. Both companies raised capital aggressively during low-rate conditions and had to reckon sharply with investor skepticism when macro conditions shifted. Oscar Health vs Upstart lays out the loss ratio trends, unit economics evolution, and path to sustainable profitability that define whether either company's growth thesis has actually matured.

Oscar Health sells individual and small-group health insurance plans powered by its own technology platform while Upstart uses AI to underwrite personal and auto loans at a pace that traditional lende...

Comparison Snapshot

Key Financial Metrics

OSCR

Metric

UPST

$4.95B

Market Cap

$3.14B

-4.76%

Potential Profit

81.20%

Hold

Analyst Rating

Buy

Discover More Comparisons

Oscar Health vs Selective

Oscar Health bets its future on tech-driven health insurance for individuals while Selective Insurance has spent over a century quietly compounding in the commercial property-casualty market. Both operate within the broader insurance industry, but their risk profiles, customer bases, and growth trajectories are miles apart. The Oscar Health vs Selective comparison reveals which insurer delivers more compelling financials and whether Oscar's disruptive model can match Selective's proven underwriting discipline.

Oscar Health vs Lemonade

Oscar Health built a tech-forward health insurance platform targeting individual and small-group markets with a digital-first member experience, while Lemonade set out to reinvent property and casualty insurance with AI-driven claims processing and a B-Corp charitable giving model. Both are insurtech companies that raised enormous amounts of capital on the promise that technology could make insurance faster, cheaper, and less adversarial, yet both have faced hard questions about underwriting losses and the path to profitability. The Oscar Health vs Lemonade comparison puts two high-profile insurance disruptors side by side to see whose loss ratios, growth rates, and capital runway tell a more convincing story about eventual viability.

Oscar Health vs Lazard

Oscar Health is a tech-driven health insurer chasing profitability in the individual market, while Lazard is a century-old financial advisory firm monetizing relationships at the top of global M&A and restructuring. They're both navigating fee-intensive business models, but that's where the similarities end. The Oscar Health vs Lazard comparison breaks down how growth trajectory, margin structure, and revenue predictability differ across these two distinct financial services plays.

Investment Analysis

Oscar Health

OSCR

Pros

Oscar Health has demonstrated strong revenue growth, with analysts forecasting a 12.5% annual increase through 2027.
The company achieved record membership growth and improved operational efficiency, with its lowest SG&A ratio in history.
Oscar Health leverages technology and data analytics to enhance member experience and maintain disciplined medical cost management.

Considerations

Oscar Health continues to report net losses, with negative earnings per share and a negative price-to-earnings ratio.
Analyst consensus and price targets suggest significant downside, with average targets well below current market price.
The stock exhibits high volatility, with a beta above 1.8, indicating greater risk compared to the broader market.

Upstart

UPST

Pros

Upstart has established a leading AI-driven lending platform, enabling banks to improve credit decisioning and reduce defaults.
The company has shown strong revenue growth, driven by expanding partnerships and increasing loan volume through its platform.
Upstart maintains a scalable business model with high gross margins and limited direct credit risk exposure.

Considerations

Upstart's financial performance is highly sensitive to macroeconomic conditions and interest rate fluctuations.
The company has faced regulatory scrutiny and legal challenges related to its lending algorithms and compliance practices.
Upstart's stock has experienced significant volatility and valuation swings, reflecting uncertainty in its growth trajectory.

Related Market Insights

Google PayPal AI Deal: Could This Change Shopping?

Explore the Google PayPal AI deal transforming shopping. Invest in the future of AI payments & autonomous commerce with Nemo's expert-curated Neme. Discover key companies.

Aimee Silverwood | Financial Analyst

September 18, 2025

Read Insight

The Digital Empowerment Revolution: Why Control is the New Currency

Invest in the Digital Empowerment Neme. Discover 15 companies putting control in users' hands across fintech & smart home tech. Start investing with Nemo.

Aimee Silverwood | Financial Analyst

July 25, 2025

Read Insight

The Data Advantage: Why Information Asymmetry Creates Investment Gold

Discover how companies monetize information asymmetry for profit. Explore the Data Advantage Neme, featuring firms with proprietary data & superior analytics. Invest with Nemo.

Oscar Health (OSCR)

Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.

Upstart (UPST)

Upstart Holdings (UPST) operates a technology-driven lending platform that connects borrowers with banks and also offers loans it holds on balance sheet. The company uses machine-learning models to assess creditworthiness and prize underwriting signals beyond traditional FICO scores, aiming to increase approval rates while managing default risk. Revenue derives from origination and servicing fees, interest income on held loans and platform fees from bank partners. Investors should note sensitivity to credit cycles, model performance and data drift, funding costs, and potential regulatory scrutiny around algorithmic lending. Upstart has experienced periods of rapid growth and volatility; future profit depends on charge-offs, loan volumes and funding conditions. This is general educational information, not personalised advice — values can fall as well as rise and past performance is not a guide to the future.

Which Baskets Do They Appear In?

Google PayPal AI Deal: Could This Change Shopping?

Google and PayPal have announced a strategic partnership to develop AI-powered shopping and payment solutions. This collaboration creates an investment opportunity in the broader ecosystem of companies involved in AI, e-commerce, and digital payments that will support this new standard.

Published: September 18, 2025

Explore Basket

Expert-Backed Future Stars

This collection features emerging companies that have earned strong backing from financial experts and analysts. These carefully selected stocks represent innovative businesses with exceptional growth potential, positioned to become the market leaders of tomorrow.

Published: June 18, 2025

Explore Basket

Alternative Data Providers

Discover companies that collect and analyze unconventional data to create market advantages. These carefully selected stocks represent firms turning satellite imagery, web data, and consumer transactions into valuable insights that can lead to better investment decisions.

Get exclusive access to ambitious challenger companies positioned to outperform their larger competitors. Our professional analysts have carefully selected these nimble innovators for their potential to deliver explosive growth by disrupting established industry giants.

Published: June 17, 2025

Explore Basket

Oscar Health vs Upstart

Comparison Snapshot